Decreased lung function in one year survivors of allogeneic bone marrow transplantation conditioned with high-dose busulphan and cyclophosphamide
Authors:
- J KongerudJKJ Kongerud
- L BrinchLBL Brinch
- Sa EvensenSESa Evensen
- J BoeJBJ Boe
Open Access
- 1 August 1995
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 8 (8) , 1269-1274
Abstract
Conditioning with busulphan (BU) and cyclophosphamide (CY) prior to allogeneic bone marrow transplantation (BMT) is an alternative to regimens that include total body irradiation (TBI). The aim of the study was to assess the occurrence and degree of lung function impairment after this treatment. Prospectively, 43 consecutive patients, aged 17-51 (median 31) yrs, were examined by lung function measurements and clinical and radiographic evaluation, prior to BMT and at 3 month intervals up to 1 yr after BMT. All patients had normal chest radiographs before BMT and at the 12 month follow-up. Mean baseline values were above 100% of predicted normal for lung volumes and above 90% for gas transfer. Excluded from the lung function follow-up analyses were nine patients who had suffered infectious pneumonia and/or developed obliterative bronchiolitis. For the remaining patients (n = 34), mean alveolar volume (VA), forced vital capacity (FVC) and forced expiratory volume in one second (FEV1) had dropped by nearly 10% compared with baseline 3 months after BMT, but were restored within 1 yr. FEV1/FVC x 100 (FEV1%) was increased, reflecting the restrictive pattern. Hb-adjusted transfer factor of the lungs for carbon monoxide (TL,CO) had dropped by 20% after 3 months, and remained reduced by 15% after 1 year. Prior to BMT the smokers had significantly lower TL,CO than the nonsmokers, and after BMT the difference was accentuated. Reductions in lung function were independent of sex, age and type of haematological disorder. We conclude that BMT with BU/CY is associated with transient declines in lung volumes and a persistent reduction in gas transfer 1 yr after therapy.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 20 references indexed in Scilit:
- A CHRONIC PULMONARY SYNDROME ASSOCIATED WITH GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC MARROW TRANSPLANTATIONTransplantation, 1992
- Prospective evaluation of pulmonary function in cancer patients treated with total body irradiation, high-dose melphalan, and autologous hematopoietic stem cell transplantationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1990
- Enhanced pulmonary toxicity in smokers with germ-cell cancer treated with Cis-platinum, vinblastine and bleomycin: A long-term follow-upEuropean Journal of Cancer and Clinical Oncology, 1989
- Small-Airways Disease in Recipients of Allogeneic Bone Marrow TransplantsMedicine, 1987
- Lung function changes after allogenic bone marrow transplantation.Thorax, 1986
- Reduced lung function in leukaemia patients undergoing bone marrow transplantationScandinavian Journal of Haematology, 1984
- Fatal pulmonary fibrosis occurring during treatment with cyclophosphamide.BMJ, 1982
- Cyclophosphamide and Interstitial PneumonitisJAMA, 1980
- Cyclophosphamide pneumonitis.Thorax, 1978
- Iron-Deficiency Anaemia: Its Effect on Transfer Factor for the Lung (Diffusing Capacity) and Ventilation and Cardiac Frequency during Sub-Maximal ExerciseClinical Science, 1972